Metraipolis › archive › dc_32c588685eb6

Discontinuation and reinitiation of pharmacological treatment for ADHD among individuals with ADHD and substance use disorder — Europe PMC PMID:41871884

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41871884
DOI
10.1136/bmjment-2025-302138
License (as archived)
solo-consultazione
Archived
2026-11-04T02:22:34.007Z
SHA-256 of the archived text
c0e275ded6e9bb498f3a93b0e62dd303879ec93b948a1f3ffea77b748d205eab
Stable URL of this page
https://metraipolis.com/documento/dc_32c588685eb6

How to cite

Discontinuation and reinitiation of pharmacological treatment for ADHD among individuals with ADHD and substance use disorder — Europe PMC PMID:41871884 — Europe PMC (en), https://europepmc.org/article/MED/41871884 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32c588685eb6 (Metraipolis archive dc_32c588685eb6, sha256 c0e275ded6e9bb498f3a93b0e62dd303879ec93b948a1f3ffea77b748d205eab)
BibTeX
@misc{dc32c588685eb6,
  title = {Discontinuation and reinitiation of pharmacological treatment for ADHD among individuals with ADHD and substance use disorder — Europe PMC PMID:41871884},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41871884},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32c588685eb6; sha256 c0e275ded6e9bb498f3a93b0e62dd303879ec93b948a1f3ffea77b748d205eab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41871884. Agents can read the archived copy with the MCP tool read_document.